Lori Berard

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Type 2 Diabetes Mellitus Management in Canada: Is It Improving?

Lawrence A. Leiter, Lori Berard, C. Keith Bowering et al. · Canadian Journal of Diabetes · 2013 · 157 citations

Disease Management, Diabetes Management, Primary Care +8

Self-Management Education and Support

Diana Sherifali, Lori Berard, Enza Gucciardi et al. · Canadian Journal of Diabetes · 2018 · 106 citations

Self-management Education, Self-management, Management Education +5

Monitoring Glycemic Control

Lori Berard, Ian Blumer, Robyn L. Houlden et al. · Canadian Journal of Diabetes · 2013 · 92 citations · Full text

Diabetes, Digital Health, Wearable Technology +6